| 1 |
张祖华, 尹晓新, 熊婧,等. 抗KLHL11抗体脑炎患者临床特征分析(附1例报告及文献复习) [J]. 中国临床神经科学, 2024, 32(1): 84-91.
|
| 2 |
魏爱芹, 郭晓敏. 以非惊厥性癫痫持续状态为主要表现的抗Amphiphysin抗体相关自身免疫性脑炎一例报道并文献复习 [J]. 实用心脑肺血管病杂志, 2022, 30(10): 137-140.
|
| 3 |
Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma [J]. Ann Neurol, 2007, 61(1): 25-36.
|
| 4 |
Ren H, Fan S, Zhao Y, et al. The changing spectrum of antibody-mediated encephalitis in China [J]. J Neuroimmunol, 2021, 361: 577753.
|
| 5 |
Yao L, Yue W, Xunyi W, et al. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China [J]. J Clin Neurosci, 2019, 68: 73-79.
|
| 6 |
VanHaerents S, Gerard EE. Epilepsy emergencies: status epilepticus, acute repetitive seizures, and autoimmune encephalitis [J]. Continuum (Minneap Minn), 2019, 25(2): 454-476.
|
| 7 |
Tarnutzer AA, Lee SH, Robinson KA, et al. Clinical and electrographic findings in epileptic vertigo and dizziness: a systematic review [J]. Neurology, 2015, 84(15): 1595-1604.
|
| 8 |
Jiang Y, Zhou X. Frontal lobe epilepsy manifesting as vertigo: a case report and literature review [J]. J Int Med Res, 2020, 48(9): 300060520946166.
|
| 9 |
Surmeli R, Yalcin AD, Surmeli M, et al. Vertiginous epilepsy: documentation of clinical and electrophysiological findings of nine patients [J]. Epileptic Disord, 2020, 22(6): 775-781.
|
| 10 |
徐美慧. 自身免疫性脑炎患者临床特点及与临床功能结局相关因素的分析 [D]. 吉林: 吉林大学, 2023.
|
| 11 |
门玉娇, 朱辉, 韩冰, 等. 以共济失调为主要表现的抗NMDA抗体脑炎1例报道并文献复习 [J]. 中风与神经疾病杂志, 2018, 35(11): 1019-1021.
|
| 12 |
Aguiar de Sousa D, Lobo PP, Caldas AC, et al. Pure ataxia associated with N-methyl-D-aspartate receptor antibodies [J]. Parkinsonism Relat Disord, 2014, 20(5): 568-569.
|
| 13 |
Honnorat J, Cartalat-Carel S, Ricard D, et al. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies [J]. J Neurol Neurosurg Psychiatry, 2009, 80(4): 412-416.
|
| 14 |
Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis [J]. Brain, 2004, 127(Pt 8): 1831-1844.
|
| 15 |
Shioda M, Fujita H, Onuma H, et al. Gait instability, ophthalmoplegia, and chorea with orofacial dyskinesia in a man with anti-Ri antibodies: a case report [J]. Front Neurol, 2024, 15: 1359781.
|
| 16 |
Yuki N, Yoshino H, Sato S, et al. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies [J]. Muscle Nerve, 1992, 15(8): 899-903.
|
| 17 |
李云珍, 姚少濠, 李玲, 等. 400例免疫相关性周围神经病患者抗神经节苷脂抗体检测结果分析 [J]. 检验医学与临床, 2021, 18(3): 403-406.
|
| 18 |
徐杰, 乔保俊, 宋进, 等. 鲁西南地区吉兰-巴雷综合征患者常见抗神经节苷脂IgG抗体的种类及临床意义 [J]. 中国神经免疫学和神经病学杂, 2023, 30(3): 162-168.
|
| 19 |
Goodfellow JA, Bowes T, Sheikh K, et al. Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy [J]. J Neurosci, 2005, 25(7): 1620-1628.
|
| 20 |
Ho TW, Willison HJ, Nachamkin I, et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome [J]. Ann Neurol, 1999, 45(2): 168-173.
|
| 21 |
Kim SY, Kim JK, Suh CK. Polycranial neuropathy and sensory ataxia with IgG anti-GD1a antibody as a variant of Guillain-Barré syndrome [J]. J Clin Neurosci, 2013, 20(3): 473-475.
|
| 22 |
Yamagishi Y, Kuwahara M, Suzuki H, et al. Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome [J]. J Neurol Neurosurg Psychiatry, 2020, 91(12): 1339-1342.
|
| 23 |
Jazebi N, Patel C, Fang X. Antiganglioside antibodies and paraneoplastic neuromuscular junction disorder? [J]. eNeurologicalSci, 2020, 21: 100277.
|
| 24 |
刘举, 潘佳丽, 杨晓艳, 等. 14例副肿瘤性周围神经病临床特征分析 [J]. 肿瘤基础与临床, 2022, 35(4): 327-331.
|
| 25 |
Kanaji N, Kume K, Mizoguchi H, et al. Subacute sensorimotor neuropathy accompanied by anti-ganglioside GM1 antibody in a patient with lung cancer [J]. Intern Med, 2018, 57(22): 3289-3292.
|
| 26 |
De Toni L, Marconi S, Nardelli E, et al. Gangliosides act as onconeural antigens in paraneoplastic neuropathies [J]. J Neuroimmunol, 2004, 156(1-2): 178-187.
|
| 27 |
Wanleenuwat P, Iwanowski P, Kozubski W. Antiganglioside antibodies in neurological diseases [J]. J Neurol Sci, 2020, 408: 116576.
|
| 28 |
李柱一, 张巍. 免疫性神经肌肉疾病研究进展 [J]. 中国神经免疫学和神经病学杂志, 2011, 18(5): 305-309.
|
| 29 |
Kusunoki S, Tsuji S, Inoue K, et al. Combined features of myasthenia gravis and Eaton-Lambert syndrome: anti-ganglioside antibodies in serum [J]. J Neurol Sci, 1988, 87(1): 61-66.
|
| 30 |
Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study [J]. Lancet Neurol, 2013, 12(2): 157-165.
|
| 31 |
Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis [J]. Lancet Neurol, 2016, 15(4): 391-404.
|
| 32 |
Vyas S, Rodrigues AJ, Silva JM, et al. Chronic stress and glucocorticoids: from neuronal plasticity to neurodegeneration [J]. Neural Plast, 2016, 2016: 6391686.
|
| 33 |
Shimoni Z, Bulvik S, Froom P. Intravenous immune globulin in autoimmune and inflammatory diseases [J]. N Engl J Med, 2013, 368(8): 776-777.
|
| 34 |
郭江涵, 张颖. 自身免疫性脑炎的研究进展 [J]. 临床医学, 2022, 42(10): 123-126.
|
| 35 |
中华医学会神经病学分会神经感染性疾病与脑脊液细胞学学组. 中国自身免疫性脑炎诊治专家共识(2022年版) [J]. 中华神经病学, 2022, 55(9): 931-949.
|